abbvie glp-1 receptor agonist weight management diabetes treatments Evolution of GLP‐1 Agonists for Treatment Mechanisms of GLP-1 Receptor Agonist-Induced

[DOI] [PubMed] [Google Scholar] 78.McMurray J.J.V., Ponikowski P., Bolli G.B., Lukashevich V., Kozlovski P., Kothny W., Lewsey J.D., Krum H., VIVIDD Trial Committees and Investigators Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

But what happens when you add a GLP-1RA

Mol Metab 2021;51:101237.ArticlePubMedPMC 10

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene

Under these conditions, metabolism shifts toward increased reliance on lipid-derived substrates and elevated oxidative throughput

Across the full GLP-1 and obesity drug space, the post-2026 picture is a price-expansion wave led by Indian and Chinese biosimilars and by new dual or triple-agonist molecules, yet real uptake in the USA and EU will be shaped less by tariffs and more by regulatory timing, drug-device parity on pens and human-factors equivalence for AB-substitution, secondary IP and Orange Book hurdles, and payer or formulary contracting